Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,690,355
-
Total 13F shares
-
166,095,520
-
Share change
-
+321,115
-
Total reported value
-
$1,767,006,761
-
Put/Call ratio
-
7.1%
-
Price per share
-
$10.64
-
Number of holders
-
249
-
Value change
-
+$4,551,974
-
Number of buys
-
142
-
Number of sells
-
106
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) as of Q2 2023
As of 30 Jun 2023,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) was held by
249 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
166,095,520 shares.
The largest 10 holders included
BlackRock Inc., Sarissa Capital Management LP, VANGUARD GROUP INC, STATE STREET CORP, LSV ASSET MANAGEMENT, CREDIT SUISSE AG/, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, BROWN CAPITAL MANAGEMENT LLC, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
249
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.